Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Freeze-dried Group ACYW135 Meningococcal Conjugate Vaccine
NCT02481232Phase 1Unknown
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 1, open-label trial in meningococcal meningitis (2 arms), sponsored by Lanzhou Institute of Biological Products Co., Ltd. Primary endpoint: Systemic and local reactions at 30 days. Status: unknown.
02
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT02481232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481232.